These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1617167)

  • 1. Viral antigen presentation and MHC assembly.
    Braciale TJ; Braciale VL
    Semin Immunol; 1992 Apr; 4(2):81-4. PubMed ID: 1617167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
    J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?
    Long EO; Jacobson S
    Immunol Today; 1989 Feb; 10(2):45-8. PubMed ID: 2665772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-restricted recognition of viral antigens in HLA transgenic mice.
    Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
    Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I antigen presentation.
    Jelachich ML; Biddison WE
    Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of the HLA system in the functioning of the immune system].
    Renier G
    Allerg Immunol (Paris); 1992 Apr; 24(4):123-6. PubMed ID: 1642761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Sigal LJ; Crotty S; Andino R; Rock KL
    Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and intracellular transport of major histocompatibility complex molecules.
    Neefjes JJ; Schumacher TN; Ploegh HL
    Curr Opin Cell Biol; 1991 Aug; 3(4):601-9. PubMed ID: 1837724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
    Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
    J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background.
    Lo-Man R; Martineau P; Hofnung M; Leclerc C
    Cell Immunol; 1996 Sep; 172(2):180-91. PubMed ID: 8964079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some cloned murine CD4+ T cells recognize H-2Ld class I MHC determinants directly. Other cloned CD4+ T cells recognize H-2Ld class I MHC determinants in the context of class II MHC molecules.
    McKisic MD; Sant AJ; Fitch FW
    J Immunol; 1991 Nov; 147(9):2868-74. PubMed ID: 1717578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of viral antigen controlled by a gene in the major histocompatibility complex.
    Cerundolo V; Alexander J; Anderson K; Lamb C; Cresswell P; McMichael A; Gotch F; Townsend A
    Nature; 1990 May; 345(6274):449-52. PubMed ID: 2342577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells down-modulate peptide-MHC complexes on APCs in vivo.
    Kedl RM; Schaefer BC; Kappler JW; Marrack P
    Nat Immunol; 2002 Jan; 3(1):27-32. PubMed ID: 11731800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure and function of MHC molecules. Possible implications for the control of tumor growth by MHC-restricted T cells.
    Kourilsky P; Jaulin C; Ley V
    Semin Cancer Biol; 1991 Oct; 2(5):275-82. PubMed ID: 1773044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells.
    Cardoso AI; Beauverger P; Gerlier D; Wild TF; Rabourdin-Combe C
    Virology; 1995 Sep; 212(1):255-8. PubMed ID: 7676641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
    Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
    Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological memory against viruses.
    Ahmed R
    Semin Immunol; 1992 Apr; 4(2):105-9. PubMed ID: 1535520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.